Advancing China–Indonesia Medical Cooperation to a New Level

Beijing, November, 2025 — GoBroad Healthcare Group and Rumah Sakit Sentra Medika Cibinong of Indonesia officially signed a Strategic Memorandum of Understanding (MOU). The partnership marks a significant step forward in bilateral cooperation in oncology and hematology care, clinical research, and talent development, opening a new chapter in China–Indonesia medical collaboration.

Leaders from Both Sides Attend the Ceremony

A delegation from Sentra Medika Hospital Group (SMHG), led by Dr. Fransisca Mayer, Managing Director of SMHG, visited Beijing to participate in the signing ceremony. The delegation included experts in medical services, pediatric hematology-oncology, and business development.

GoBroad Healthcare Group was represented by Ms. Nan Gao, Vice President of Market Strategy & International Business; Mr. Hua Shang, Executive Director of Beijing GoBroad Hospital; among other managements and clinical experts.

A Collaboration Focused on Clinical Excellence, Research Innovation and Talent Development

Under the newly signed MOU, the two organizations will strengthen cooperation across several strategic domains, including high-level medical exchange, capacity building in oncology and hematology, joint clinical research, enhancement of innovative therapy accessibility, and the development of standardized training programs. Through coordinated efforts in clinical practice, scientific innovation, and talent development, the partnership aims to elevate care quality, accelerate research translation, and broaden treatment options for Indonesian patients.

Complementary Strengths to Advance Regional Healthcare Capacity

Sentra Medika Hospital Group, with over 41 years of development, operates multiple general hospitals across Indonesia. Cibinong Hospital holds KARS Paripurna accreditation—Indonesia’s highest hospital quality standard—and has established strong specialty capabilities in oncology, cardiovascular care, digestive diseases, and neurology. The group’s institutional profile highlights a wide range of clinical centers of excellence and advanced medical technologies, including radiotherapy, cath lab, and a comprehensive cancer center.

GoBroad Healthcare Group, a leading research-oriented medical organization in China, has established extensive expertise in hematology and oncology, having performed more than 4,000 hematopoietic stem cell transplants and 5,000 CAR-T cell therapies. GoBroad has published nearly 70 high-impact international research papers and continues to drive innovation in clinical practice and translational medicine. These complementary strengths provide a solid foundation for impactful cross-border collaboration.

Looking Ahead: Building a Model for China–Indonesia Healthcare Cooperation

With the signing of the MOU, both institutions will move quickly toward implementation, including expert exchanges, planning of joint clinical initiatives, and the launch of the first talent training programs.

GoBroad Healthcare Group and Sentra Medika Hospital Group expressed their shared commitment to building a high-quality, sustainable, and scalable partnership, with the goal of delivering better medical services and wider treatment access for patients in Indonesia and the broader region.